BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8387488)

  • 1. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion.
    Schoch C; Blumenthal R
    J Biol Chem; 1993 May; 268(13):9267-74. PubMed ID: 8387488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus.
    Gething MJ; Doms RW; York D; White J
    J Cell Biol; 1986 Jan; 102(1):11-23. PubMed ID: 3753607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exposure to low pH on the lateral mobility of influenza hemagglutinin expressed at the cell surface: correlation between mobility inhibition and inactivation.
    Gutman O; Danieli T; White JM; Henis YI
    Biochemistry; 1993 Jan; 32(1):101-6. PubMed ID: 8418830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
    Melikyan GB; Jin H; Lamb RA; Cohen FS
    Virology; 1997 Aug; 235(1):118-28. PubMed ID: 9300043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.
    Danieli T; Pelletier SL; Henis YI; White JM
    J Cell Biol; 1996 May; 133(3):559-69. PubMed ID: 8636231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.
    Clague MJ; Schoch C; Blumenthal R
    J Virol; 1991 May; 65(5):2402-7. PubMed ID: 1850019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermonomer disulfide bonds impair the fusion activity of influenza virus hemagglutinin.
    Kemble GW; Bodian DL; Rosé J; Wilson IA; White JM
    J Virol; 1992 Aug; 66(8):4940-50. PubMed ID: 1629960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.
    Simpson DA; Lamb RA
    J Virol; 1992 Feb; 66(2):790-803. PubMed ID: 1309913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
    Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
    J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment.
    Philipp HC; Schroth B; Veit M; Krumbiegel M; Herrmann A; Schmidt MF
    Virology; 1995 Jun; 210(1):20-8. PubMed ID: 7793071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.
    Steinhauer DA; Wharton SA; Wiley DC; Skehel JJ
    Virology; 1991 Sep; 184(1):445-8. PubMed ID: 1871979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of acidic residues in the "fusion segment" of influenza A virus hemagglutinin in low-pH-dependent membrane fusion.
    Nobusawa E; Hishida R; Murata M; Kawasaki K; Ohnishi S; Nakajima K
    Arch Virol; 1995; 140(5):865-75. PubMed ID: 7605199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway.
    Roth MG; Doyle C; Sambrook J; Gething MJ
    J Cell Biol; 1986 Apr; 102(4):1271-83. PubMed ID: 3007532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin.
    Veit M; Kretzschmar E; Kuroda K; Garten W; Schmidt MF; Klenk HD; Rott R
    J Virol; 1991 May; 65(5):2491-500. PubMed ID: 1901916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.
    Dong J; Roth MG; Hunter E
    J Virol; 1992 Dec; 66(12):7374-82. PubMed ID: 1331528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
    Korte T; Epand RF; Epand RM; Blumenthal R
    Virology; 2001 Oct; 289(2):353-61. PubMed ID: 11689057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
    Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant influenza virus hemagglutinin that induces fusion at elevated pH.
    Doms RW; Gething MJ; Henneberry J; White J; Helenius A
    J Virol; 1986 Feb; 57(2):603-13. PubMed ID: 3003392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.